U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07257133) titled 'A Study Of Opioid Avoidance In Surgery Through Integrating Suzetrigine' on Nov. 21.
Brief Summary: This prospective, single-arm feasibility study will evaluate postoperative pain control, opioid use, and early recovery outcomes in adult patients undergoing elective outpatient facial plastic surgery who receive suzetrigine as part of their standard postoperative analgesic regimen.
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Post Operative Pain
Intervention:
DRUG: Suzetrigine
Patients will receive suzetrigine instead of the standard of care opioids.
The dosing schedule will be: a single oral loading dose...